Greece’s Health Minister Giorgiadis, speaking from Luxembourg at a European Union Health Council meeting, emphasized the critical need to bolster pharmaceutical production within Europe. He argued that access to medicines is no longer solely a health issue, but a matter of strategic autonomy, resilience, and overall European security. The Minister highlighted strengthening European drug manufacturing as a key priority for the EU. This shift in perspective reflects growing concerns about supply chain vulnerabilities and geopolitical factors impacting access to essential medications. Giorgiadis’s comments signal a move towards greater self-sufficiency in pharmaceutical production across the EU member states. The discussion focused on ensuring a stable and secure supply of drugs for European citizens. This initiative aims to reduce reliance on external sources and safeguard public health.